Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment
-
* Corresponding author: Des Breen des.breen@btinternet.com
Critical Care 2004, 8:R21-R30 doi:10.1186/cc2399
See related Commentary: http://ccforum.com/content/8/1/13
No comments have yet been made on this article.